Pin1 Antibody (Mouse mAb) [C4H20]

Catalog No.: F3803

    Application: Reactivity:
    • Lane 1: U2OS, Lane 2: Hela, Lane 3: MCF7, Lane 4: MDA-MB-453
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min,Recommended to use 0.22 μm PVDF 膜の使用をお勧めします。

    使用情報

    Dilution
    1:4000
    1:600-1:1000
    1:80-1:250
    1:80-1:250
    Application
    WB, IP, IHC
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Human, Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    18 kDa 20 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human breast cancer tissue; U20S cells; HeLa cells; MDA‑MB‑453 cells; Balb/3T3 cells; MCF‑7 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Pin1 Antibody (Mouse mAb) [C4H20] detects endogenous levels of total Pin1 protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    Q13526
    Clone
    C4H20
    Synonym(s)
    Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, Peptidyl-prolyl cis-trans isomerase Pin1 (PPIase Pin1), Rotamase Pin1, PIN1
    Background
    Pin1 is a phosphorylation-dependent peptidyl‑prolyl cis–trans isomerase of the parvulin family that recognizes phosphorylated Ser/Thr‑Pro motifs in a wide range of regulatory proteins, positioning it as a nodal modulator of proline‑directed kinase signaling in cell proliferation, survival, and stress responses. The protein contains an N‑terminal WW domain that binds pSer/Thr‑Pro motifs and a C‑terminal catalytic PPIase domain, and the spatial arrangement of these modules allows sequential docking and isomerization of substrates to couple phosphorylation status with conformational control of downstream effectors. Pin1 forms dynamic complexes with multiple protein kinases and phosphatases, including CDKs, MAPKs, GSK3, and Cdc25 phosphatases, and by altering the conformation of specific phospho‑motifs it modulates their catalytic activity, subcellular distribution, and assembly into signaling complexes that govern cell cycle transitions and checkpoint responses. The same recognition principle extends to transcription factors and chromatin‑associated regulators such as c‑Jun, NF‑κB components, β‑catenin co‑regulators, and RNA polymerase II, where Pin1‑dependent isomerization influences promoter occupancy, cofactor recruitment, and the coupling between transcription initiation, elongation, termination, and mRNA decay. Within the transcriptional machinery, Pin1 interacts with the phosphorylated C‑terminal domain of RNAPII and factors that control promoter clearance and pause‑release, thereby shaping gene expression programs linked to proliferation, differentiation, apoptosis, and immune activation. The enzyme also engages transcriptional repressors and mRNA stability factors, so that proline‑directed phosphorylation combined with Pin1‑mediated conformational switching coordinates transcriptional output with post‑transcriptional control for sets of genes involved in cytokine production and cell fate decisions. At the protein level, Pin1 frequently regulates the balance between stabilization and degradation by influencing recognition of phosphoproteins by ubiquitin ligases or deubiquitinases, which affects steady‑state levels of key substrates such as cyclin regulators, oncogenic transcription factors, and tumor suppressor pathway components. Through this network of interactions, Pin1 integrates signals from Ras, Wnt/β‑catenin, and other oncogenic pathways, reinforcing expression and activity of drivers of cell cycle progression while modulating checkpoint and DNA damage response proteins in a phosphorylation‑ and conformation‑dependent manner. Pin1 is expressed in many tissues and operates in both nuclear and cytoplasmic compartments, where its activity is subject to control by post‑translational modifications on regulatory residues that influence substrate binding and catalytic efficiency, embedding an additional regulatory tier into signaling cascades. Dysregulated Pin1 expression and activity associate with a broad spectrum of pathologies, particularly cancer, in which elevated Pin1 enhances multiple oncogenic circuits and perturbs transcriptional homeostasis, and with neurological and immune disorders in which altered control of neuronal or inflammatory gene expression contributes to disease processes.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください